{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:38Z","timestamp":1791308858868,"version":"4.3.1"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T00:00:00Z","timestamp":1323734400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0028445","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T21:53:22Z","timestamp":1323813202000},"page":"e28445","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Vaccination with M2e-Based Multiple Antigenic Peptides: Characterization of the B Cell Response and Protection Efficacy in Inbred and Outbred Mice"],"prefix":"10.1371","volume":"6","author":[{"given":"Amaya I.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Mozdzanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Caton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Otvos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Erikson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,12,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.02.030","article-title":"A \u201cuniversal\u201d human influenza A vaccine.","volume":"103","author":"W Fiers","year":"2004","journal-title":"Virus Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.micinf.2004.10.006","article-title":"Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design.","volume":"7","author":"W Liu","year":"2005","journal-title":"Microbes Infect"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0042-6822(91)90075-M","article-title":"Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel.","volume":"180","author":"RJ Sugrue","year":"1991","journal-title":"Virology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0042-6822(91)90115-R","article-title":"Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds.","volume":"183","author":"LJ Holsinger","year":"1991","journal-title":"Virology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.","volume":"62","author":"SL Zebedee","year":"1988","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","article-title":"Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface.","volume":"40","author":"RA Lamb","year":"1985","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/JVI.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice.","volume":"64","author":"JJ Treanor","year":"1990","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1743-422X-6-224","article-title":"Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein.","volume":"6","author":"RR Beerli","year":"2009","journal-title":"Virol J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1128\/JVI.79.11.6644-6654.2005","article-title":"Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.","volume":"79","author":"D Zharikova","year":"2005","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/viro.1998.9534","article-title":"Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.","volume":"254","author":"K Mozdzanowska","year":"1999","journal-title":"Virology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.imlet.2004.03.003","article-title":"Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.","volume":"93","author":"W Liu","year":"2004","journal-title":"Immunol Lett"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1743-422X-3-102","article-title":"Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.","volume":"3","author":"J Feng","year":"2006","journal-title":"Virol J"},{"issue":"Pt 1","key":"ref13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1099\/0022-1317-74-1-143","article-title":"Antibody response to the M2 protein of influenza A virus expressed in insect cells.","volume":"74","author":"RA Black","year":"1993","journal-title":"J Gen Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1743-422X-4-118","article-title":"Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse.","volume":"4","author":"K Mozdzanowska","year":"2007","journal-title":"Virol J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(03)00040-9","article-title":"Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.","volume":"21","author":"K Mozdzanowska","year":"2003","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.vaccine.2005.08.061","article-title":"The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.","volume":"24","author":"M De Filette","year":"2006","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.vaccine.2006.05.082","article-title":"Improved design and intranasal delivery of an M2e-based human influenza A vaccine.","volume":"24","author":"M De Filette","year":"2006","journal-title":"Vaccine"},{"key":"ref18","article-title":"The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine.","author":"F Wu","year":"2009","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1743-422X-7-151","article-title":"An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.","volume":"7","author":"G Zhao","year":"2010","journal-title":"Virol J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-422X-7-9","article-title":"An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.","volume":"7","author":"G Zhao","year":"2010","journal-title":"Virol J"},{"key":"ref21","article-title":"A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody.","author":"D Pejoski","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1016\/j.vaccine.2007.09.056","article-title":"Characterization of immunity induced by M2e of influenza virus.","volume":"25","author":"F Wu","year":"2007","journal-title":"Vaccine"},{"key":"ref23","article-title":"Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.","author":"F Wu","year":"2008","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.","volume":"22","author":"J Fan","year":"2004","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1.","volume":"13","author":"SM Tompkins","year":"2007","journal-title":"Emerging Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e13162","DOI":"10.1371\/journal.pone.0013162","article-title":"Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses.","volume":"5","author":"GE Price","year":"2010","journal-title":"PLoS ONE"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1038\/mt.2010.202","article-title":"A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge.","volume":"18","author":"D Zhou","year":"2010","journal-title":"Mol Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/eji.200636959","article-title":"Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.","volume":"38","author":"J Bessa","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e9812","DOI":"10.1371\/journal.pone.0009812","article-title":"Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret.","volume":"5","author":"SS Rao","year":"2010","journal-title":"PLoS ONE"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.vaccine.2008.12.034","article-title":"Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys.","volume":"27","author":"T-M Fu","year":"2009","journal-title":"Vaccine"},{"key":"ref31","article-title":"Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.","author":"M De Filette","year":"2008","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virol.2005.04.004","article-title":"Universal influenza A vaccine: optimization of M2-based constructs.","volume":"337","author":"M De Filette","year":"2005","journal-title":"Virology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein.","volume":"5","author":"S Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1074\/jbc.M800650200","article-title":"An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.","volume":"283","author":"M De Filette","year":"2008","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.","volume":"26","author":"JW Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e14442","DOI":"10.1371\/journal.pone.0014442","article-title":"Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin.","volume":"5","author":"HK Talbot","year":"2010","journal-title":"PLoS ONE"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1016\/j.vaccine.2010.06.069","article-title":"Genetic control of immune responses to influenza A matrix 2 protein (M2).","volume":"28","author":"JA Misplon","year":"2010","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e21937","DOI":"10.1371\/journal.pone.0021937","article-title":"Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice.","volume":"6","author":"MR Soboleski","year":"2011","journal-title":"PLoS ONE"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.vaccine.2009.09.130","article-title":"Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates.","volume":"28","author":"P Kitikoon","year":"2009","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11262-010-0547-7","article-title":"Influenza A viruses: why focusing on M2e-based universal vaccines.","volume":"42","author":"SM Ebrahimi","year":"2011","journal-title":"Virus Genes"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1016\/j.vaccine.2009.07.007","article-title":"M2e-based universal influenza A vaccine.","volume":"27","author":"W Fiers","year":"2009","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-59745-419-3_15","article-title":"Synthesis of a multivalent, multiepitope vaccine construct.","volume":"494","author":"L Otvos","year":"2008","journal-title":"Methods Mol Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1002\/1521-4141(200112)31:12<3816::AID-IMMU3816>3.0.CO;2-K","article-title":"Rationally designed strings of promiscuous CD4(+) T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines.","volume":"31","author":"F Falugi","year":"2001","journal-title":"Eur J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0092-8674(93)90306-B","article-title":"Promiscuous and allele-specific anchors in HLA-DR-binding peptides.","volume":"74","author":"J Hammer","year":"1993","journal-title":"Cell"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.4049\/jimmunol.148.12.3970","article-title":"A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.","volume":"148","author":"JL Greenstein","year":"1992","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.vaccine.2009.12.058","article-title":"Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination.","volume":"28","author":"HM Joo","year":"2010","journal-title":"Vaccine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.","volume":"172","author":"A Jegerlehner","year":"2004","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7883\/yoken.JJID.2005.195","article-title":"Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.","volume":"58","author":"S-i Tamura","year":"2005","journal-title":"Jpn J Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.","volume":"59","author":"RJ Cox","year":"2004","journal-title":"Scand J Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.4049\/jimmunol.168.6.2930","article-title":"Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines.","volume":"168","author":"Y Asahi","year":"2002","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/eji.1830210602","article-title":"Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.","volume":"21","author":"S Tamura","year":"1991","journal-title":"Eur J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1128\/JVI.65.4.2146-2148.1991","article-title":"Immunoglobulin A mediation of murine nasal anti-influenza virus immunity.","volume":"65","author":"KB Renegar","year":"1991","journal-title":"Journal of Virology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.","volume":"173","author":"KB Renegar","year":"2004","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1016\/j.vaccine.2008.09.057","article-title":"Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.","volume":"26","author":"N Hagenaars","year":"2008","journal-title":"Vaccine"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-422X-7-9","article-title":"An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.","volume":"7","author":"G Zhao","year":"2010","journal-title":"Virol J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.molimm.2005.12.015","article-title":"Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.","volume":"43","author":"M Zhang","year":"2006","journal-title":"Mol Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/336778a0","article-title":"A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.","volume":"336","author":"F Sinigaglia","year":"1988","journal-title":"Nature"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1128\/IAI.01151-06","article-title":"A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.","volume":"74","author":"JM Calvo-Calle","year":"2006","journal-title":"Infect Immun"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1568-9972(03)00031-4","article-title":"Immunogenetics of the response to HBsAg vaccination.","volume":"2","author":"DR Milich","year":"2003","journal-title":"Autoimmun Rev"},{"key":"ref60","first-page":"329","article-title":"H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin.","volume":"72","author":"Y Hirabayashi","year":"1991","journal-title":"Immunology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0105-2896.2004.00148.x","article-title":"Use of CpG oligodeoxynucleotides as immune adjuvants.","volume":"199","author":"DM Klinman","year":"2004","journal-title":"Immunol Rev"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4049\/jimmunol.182.2.871","article-title":"Plasmacytoid dendritic cells are dispensable during primary influenza virus infection.","volume":"182","author":"AI Wolf","year":"2009","journal-title":"J Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.152.4.1653","article-title":"Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity.","volume":"152","author":"S Liang","year":"1994","journal-title":"J Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4049\/jimmunol.148.1.212","article-title":"Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.","volume":"148","author":"PA Scherle","year":"1992","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0028445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T20:56:48Z","timestamp":1713214608000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0028445"}},"subtitle":[],"editor":[{"given":"Stephen Mark","family":"Tompkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,13]]},"references-count":64,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0028445","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,13]]}}}